166 related articles for article (PubMed ID: 14574172)
1. Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys.
Eisinger F; Stoppa-Lyonnet D; Lasset C; Vennin P; Chabal F; Noguès C; Moatti JP; Sobol H; Julian-Reynier C
Fam Cancer; 2001; 1(3-4):157-62. PubMed ID: 14574172
[TBL] [Abstract][Full Text] [Related]
2. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.
Julian-Reynier CM; Bouchard LJ; Evans DG; Eisinger FA; Foulkes WD; Kerr B; Blancquaert IR; Moatti JP; Sobol HH
Cancer; 2001 Aug; 92(4):959-68. PubMed ID: 11550171
[TBL] [Abstract][Full Text] [Related]
3. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
Eur J Hum Genet; 2000 Mar; 8(3):204-8. PubMed ID: 10780786
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
5. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Eisen A; Rebbeck TR; Wood WC; Weber BL
J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
[TBL] [Abstract][Full Text] [Related]
7. International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.
Den Heijer M; van Asperen CJ; Harris H; Nippert I; Schmidtke J; Bouhnik AD; Julian-Reynier C; Evans DG; Tibben A
Eur J Cancer; 2013 Sep; 49(13):2798-805. PubMed ID: 23692813
[TBL] [Abstract][Full Text] [Related]
8. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery.
Kuerer HM; Hwang ES; Anthony JP; Dudley RA; Crawford B; Aubry WM; Esserman LJ
Ann Surg Oncol; 2000 Jun; 7(5):325-32. PubMed ID: 10864338
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
Johns D; Agarwal J; Anderson L; Ying J; Kohlmann W
J Womens Health (Larchmt); 2017 Jun; 26(6):702-706. PubMed ID: 27922795
[TBL] [Abstract][Full Text] [Related]
10. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.
Finch A; Metcalfe K; Lui J; Springate C; Demsky R; Armel S; Rosen B; Murphy J; Elit L; Sun P; Narod S
Clin Genet; 2009 Mar; 75(3):220-4. PubMed ID: 19263514
[TBL] [Abstract][Full Text] [Related]
11. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.
Tambor ES; Bernhardt BA; Geller G; Helzlsouer KJ; Doksum T; Holtzman NA
J Womens Health Gend Based Med; 2000 Apr; 9(3):223-33. PubMed ID: 10787220
[TBL] [Abstract][Full Text] [Related]
12. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
JAMA; 2000 Feb; 283(5):617-24. PubMed ID: 10665701
[TBL] [Abstract][Full Text] [Related]
13. Prevention and genetic testing for breast cancer: variations in medical decisions.
Bouchard L; Blancquaert I; Eisinger F; Foulkes WD; Evans G; Sobol H; Julian-Reynier C
Soc Sci Med; 2004 Mar; 58(6):1085-96. PubMed ID: 14723904
[TBL] [Abstract][Full Text] [Related]
14. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
15. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
Grann VR; Panageas KS; Whang W; Antman KH; Neugut AI
J Clin Oncol; 1998 Mar; 16(3):979-85. PubMed ID: 9508180
[TBL] [Abstract][Full Text] [Related]
16. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy.
van Roosmalen MS; Verhoef LC; Stalmeier PF; Hoogerbrugge N; van Daal WA
J Clin Oncol; 2002 Apr; 20(8):2092-100. PubMed ID: 11956270
[TBL] [Abstract][Full Text] [Related]
17. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
Dowdy SC; Stefanek M; Hartmann LC
Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
[TBL] [Abstract][Full Text] [Related]
18. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
[TBL] [Abstract][Full Text] [Related]
19. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
[TBL] [Abstract][Full Text] [Related]
20. Breast and ovarian cancer prone women and prophylactic surgery temptation.
Eisinger F; Julian-Reynier C; Stoppa-Lyonnet D; Vennin P; Lasset C; Noguès C; Sobol H
J Clin Oncol; 1998 Jul; 16(7):2573-5. PubMed ID: 9667284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
